Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Open in API
Filings indexed 428 across all filing types
Latest filing 2020-07-23 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings
2020-07-23 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter from Bigshare Services Pvt Ltd confirming compliance with regulations related to dematerialization of securities for Vaishali Pharma Limited. It references SEBI regulations and confirms that securities received for dematerialization up to June 30, 2020, were processed and listed appropriately. The document is short (1674 characters) and serves as a confirmation or certification rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is primarily a regulatory compliance confirmation letter related to securities dematerialization, which fits best under Regulatory Filings (RNS) as a miscellaneous regulatory compliance document.
2020-07-21 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated July 14, 2020, from Vaishali Pharma Limited announcing the successful launch of a new product, Vipravita C, an immunity booster Vitamin C supplement. It is addressed to the National Stock Exchange of India and includes details about the product variants, company background, and a statement from the Managing Director. There are no financial statements, regulatory filings, or detailed financial performance data included. The document is promotional and informative about a product launch rather than a financial report or regulatory filing. Therefore, it fits best under the category of a general regulatory announcement or miscellaneous filing. Given the absence of financial data or meeting materials, the most appropriate classification is Regulatory Filings (RNS).
2020-07-14 English
Appointment
Regulatory Filings Classification · 90% confidence The document is very short (297 characters) and contains only a brief table with personal details such as name, membership number, qualifications, and experience. There is no indication of financial data, regulatory announcements, or any report content. It does not fit any specific report or announcement category. Given the lack of context and content, the best fit is the fallback category Regulatory Filings (RNS).
2020-07-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015. It references the timing of the trading window closure related to the declaration of audited or unaudited financial results but does not contain any financial data or results itself. The document is an announcement about regulatory compliance and insider trading policy, not a financial report or earnings release. It is also relatively short (1992 characters) and serves as an official notification to the stock exchange. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-06-30 English
Press Release
Regulatory Filings
2020-06-24 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.